0001203311-20-000088.txt : 20200820 0001203311-20-000088.hdr.sgml : 20200820 20200820182701 ACCESSION NUMBER: 0001203311-20-000088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200818 FILED AS OF DATE: 20200820 DATE AS OF CHANGE: 20200820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMPSON TODD E CENTRAL INDEX KEY: 0001216477 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 201121077 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-08-18 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001216477 SIMPSON TODD E 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 Chief Financial Officer Common Stock 2020-08-18 4 S 0 9262 158.1688 D 142554 D Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. By: /s/ Jean Liu For: Todd E. Simpson 2020-08-20